Expert for Drug Development, Biotechnology and Leadership of International Teams
Thekla Kurz has more than 20 years of experience in the development of small molecule or protein drugs and cosmetic actives.
Trained as a pharmacist with a PhD in Pharmaceutical Technology she started in 1992 as laboratory head at Merck KGaA. She stayed 23 years with Merck in roles with growing responsibility as group leader and department head in the development and manufacture of drugs as well as in project and launch management. In 2015 she joined IDT Biologika, a mid-sized company being specialized in vaccines, as Vice President for the manufacture of vaccines at three different sites in Germany and the US.
Thekla has comprehensive experiences in the leadership of global teams with up to 250 employees. In parallel she holds a lectureship at the TU Darmstadt on "Development of protein drugs" in the Master of Biomolecular Engineering.
- Biosimilars, the "generics" of protein drugs
- Biotechnology - what is this all about?
- Forming international teams in a global organization
- The way of an active ingredient to a drug product
Gern senden wir Ihnen weitere Informationen zu dieser Expertin.
Nutzen Sie dafür unsere Wunschliste.